Contemporary management of chronic stable angina

Drugs and Aging

Volumn 18, Issue 2, 2001, Pages 109-121

  Staniforth, Andrew D ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANGINA PECTORIS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANGINA PECTORIS; CORONARY RISK; DIABETES MELLITUS; HUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

EID: 0035056817     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200118020-00004     Document Type: Review

References (70)

1. Prevalence of ischaemic heart disease in middle aged British men
2. Prevalence of coronary heart disease in Scotland: Scottish heart study
3. Incidence, clinical characteristics, and short-term prognosis of angina pectoris
4. Asymptomatic Cardiac Ischaemic Pilot (ACIP) study two year follow-up
5. Characteristics of a contemporary population with angina pectoris
6. Investigation and management of stable angina: Revised guidelines 1998
7. Management of stable angina pectoris
8. Guidelines for the management of patients with chronic stable angina
9. Correlation between resting segment depression, exercise testing, coronary angiography and long term prognosis
10. Guidelines for cardiac exercise testing
11. The efficacy of cardiovascular nuclear medicine exercise studies
12. Incremental prognostic power of clinical history, exercise electrocardiography and myocardial perfusion scintigraphy in patients with suspected coronary disease
13. Quality of life on angina therapy: A randomised controlled trial of transdermal glyceryl trinitrate against placebo
14. Prognostic value of myocardial perfusion imaging: State of the art and new developments
15. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease
16. Coronary angioplasty versus medical therapy for angina: The second Randomised Intervention Treatment of Angina (RITA-2) trial
17. Circadian variation of transient myocardial ischaemia in patients with coronary artery disease
18. "Maximal" drug therapy is not necessarily optimal in chronic angina pectoris
19. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
20. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris
21. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
22. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study
23. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
24. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia
25. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease
26. Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction
27. A randomized trial of propranolol in patients with acute myocardial infarction
28. Timolol induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
29. Clinical evidence that beta-adrenoreceptor blockers prevent more cardiovascular complications than other antihypertensive drugs
30. Reduced risk of death at 28 days in patients taking β blocker before admission to hospital with myocardial infarction
31. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery
32. The effect of bisoprolol on perioperative mortality and myocardial infarction in highrisk patients undergoing vascular surgery
33. Silent ischaemia during daily life is an independent predictor of mortality in stable angina
34. Effects of asymptomatic ischaemia on long-term prognosis in chronic stable coronary disease
35. Effects of treatment on outcome in mildly symptomatic patients with ischaemia during daily life
36. β-blockers or calcium antagonists in silent ischaemia
37. Medical treatment to reduce ischemic burden: The total ischemic burden Bisoprolol study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine
38. Nifedipine: Dose related increase in mortality in patients with coronary heart disease
39. The effect of diltiazem on maortality and reinfarction after myocardial infarction
40. Effect of verapamil on mortality and major events after acute myocardial infarction (DAVIT-II)
41. Effects of metoprolol vs verapamil in patients with stable angina pectoris: The Angina Prognosis Study In Stockholm (APSIS)
42. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6 week mortality and ventricular function after acute myocardial infarction
43. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction
44. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection
45. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions
46. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival and Ventricular Enlargement trial
47. Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients
48. The European trial on reduction of cardiac events with perindopril in stable coronary artery disese (EUROPA)
49. Prevention of events with angiotensin-converting enzyme inhibition (the PEACE study design)
50. Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
51. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: Meta-analysis of randomised controlled trials
52. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery
53. Long-term results of the RITA-1 trial: Clinical and cost comparisons of coronary angioplasty and coronary artery bypass grafting
54. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease
55. Morbidity and mortality in diabetics in the Framingham population study. 16-year follow-up
56. Association of glycaemia with macrovascular and microvascular disease complications of type 2 diabetes (UKPDS 35)
57. Association of systolic blood pressure with macrovascular and microvascular disease complications of type 2 diabetes (UKPDS 36)
58. Silent myocardial ischaemia in non-insulin dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography
59. Factors associated with long term survival of diabetics
60. Eight year mortality in the Emory angioplasty versus surgery trial (EAST)
61. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status
62. The effect of previous coronary artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction
63. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease
64. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina
65. Clinical outcome of patients with spinal cord stimulation for therapeutically refractory angina pectoris
66. Sympathectomuy for cardiac decompensation and coronary disease
67. Angina pectoris treated by thoracoscopic sympathectomy
68. Treatment of medically and surgically refractory angina pectoris with high thoracic epidural analgesia: Initial clinical experience
69. The innovative use of a patient-controlled analgesia pump for the management of cardiac angina